Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa (TC/RP)
Phase I Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
This PHASE1 trial investigates Retinitis Pigmentosa and is currently completed. Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE1
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Hospital Universitario Virgen de la Arrixaca
- Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
- Public Health Service, Murcia
- Red de Terapia Celular
- Spanish National Health System
For direct contact, visit the study record on ClinicalTrials.gov .